Citigroup Reiterates Neutral Rating on Baxter International Inc. (BAX)

Market Context

Baxter International Inc. operates in the Healthcare sector. The stock currently trades at $24.22 with a market capitalization of $9.7B. The stock has gained 23.9% over the past 52 weeks.

Analyst coverage from Citigroup provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Baxter International Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Baxter International Inc.

Among the 10 most recent ratings: 1 Buy, 9 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 05, 2026	Citigroup	Neutral	N/A
Jul 31, 2026	TD Cowen	Hold	N/A
Jul 31, 2026	Wells Fargo	Equal-Weight	N/A
Jul 31, 2026	Stifel	Hold	N/A
Jul 31, 2026	Citigroup	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View BAX Stock Page